The meta-analysis of these survival data further confirmed that PSMA7 overexpression was an adverse factor for breast, gastric, and liver cancers but not ovarian or lung cancers (Supplementary Fig. S6). This evidence concerns the gene PSMA7 and lung carcinoma.